Fu P - Search Results

1

MicroRNA-185 inhibits proliferation by targeting c-Met in human breast cancer cells.

Fu P, DU F, Yao M, Lv K, Liu Y. Fu P, et al. Exp Ther Med. 2014 Dec;8(6):1879-1883. doi: 10.3892/etm.2014.1999. Epub 2014 Sep 30. Exp Ther Med. 2014. PMID: 25371748 Free PMC article.

2

Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells.

Lv K, Liu L, Wang L, Yu J, Liu X, Cheng Y, Dong M, Teng R, Wu L, Fu P, Deng W, Hu W, Teng L. Lv K, et al. Among authors: fu p. PLoS One. 2012;7(7):e40008. doi: 10.1371/journal.pone.0040008. Epub 2012 Jul 9. PLoS One. 2012. PMID: 22808086 Free PMC article.

3

Lin28 mediates radiation resistance of breast cancer cells via regulation of caspase, H2A.X and Let-7 signaling.

Wang L, Yuan C, Lv K, Xie S, Fu P, Liu X, Chen Y, Qin C, Deng W, Hu W. Wang L, et al. Among authors: fu p. PLoS One. 2013 Jun 20;8(6):e67373. doi: 10.1371/journal.pone.0067373. Print 2013. PLoS One. 2013. PMID: 23840685 Free PMC article.

4

Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.

Liu Y, Du F, Chen W, Yao M, Lv K, Fu P. Liu Y, et al. Among authors: fu p. Exp Cell Res. 2013 Dec 10;319(20):3140-9. doi: 10.1016/j.yexcr.2013.08.023. Epub 2013 Sep 3. Exp Cell Res. 2013. PMID: 24012960

5

EIF5A2 is a novel chemoresistance gene in breast cancer.

Liu Y, Du F, Chen W, Yao M, Lv K, Fu P. Liu Y, et al. Among authors: fu p. Breast Cancer. 2015 Nov;22(6):602-7. doi: 10.1007/s12282-014-0526-2. Epub 2014 Mar 18. Breast Cancer. 2015. PMID: 24638963

6

Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines.

Fu P, Du F, Chen W, Yao M, Lv K, Liu Y. Fu P, et al. Oncol Rep. 2014 Jun;31(6):2561-8. doi: 10.3892/or.2014.3140. Epub 2014 Apr 16. Oncol Rep. 2014. PMID: 24737252

7

Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer.

Yao M, Liu Y, Jin H, Liu X, Lv K, Wei H, Du C, Wang S, Wei B, Fu P. Yao M, et al. Among authors: fu p. Onco Targets Ther. 2014 Sep 26;7:1743-52. doi: 10.2147/OTT.S69657. eCollection 2014. Onco Targets Ther. 2014. PMID: 25328407 Free PMC article.

8

G15 sensitizes epithelial breast cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of GPR30.

Liu Y, Du FY, Chen W, Fu PF, Yao MY, Zheng SS. Liu Y, et al. Am J Transl Res. 2015 May 15;7(5):967-75. eCollection 2015. Am J Transl Res. 2015. PMID: 26175858 Free PMC article.

9

N1-Guanyl-1,7-Diaminoheptane Sensitizes Estrogen Receptor Negative Breast Cancer Cells to Doxorubicin by Preventing Epithelial-Mesenchymal Transition through Inhibition of Eukaryotic Translation Initiation Factor 5A2 Activation.

Liu Y, Liu R, Fu P, Du F, Hong Y, Yao M, Zhang X, Zheng S. Liu Y, et al. Among authors: fu p. Cell Physiol Biochem. 2015;36(6):2494-503. doi: 10.1159/000430209. Epub 2015 Aug 10. Cell Physiol Biochem. 2015. PMID: 26279450 Free article.

10

Wogonin increases doxorubicin sensitivity by down-regulation of IGF-1R/AKT signaling pathway in human breast cancer.

Fu P, Du F, Liu Y, Hong Y, Yao M, Zheng S. Fu P, et al. Cell Mol Biol (Noisy-le-grand). 2015 Nov 30;61(7):123-7. Cell Mol Biol (Noisy-le-grand). 2015. PMID: 26638893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,873 results

Search Page